Inhibition of ocular neovascularization by plant-derived substances such as genistein;Hemmung der Neubildung von Gefassen am Auge durch Nahrungsfaktoren am Beispiel der Isoflavonoide

Ophthalmologe

Volumn 94, Issue 2, 1997, Pages 152-156

  Kruse, Friedrich E ^a,b   Joussen, Antonia M ^a   Fotsis, Theodor ^a   Schweigerer, Lothar ^a   Rohrschneider, Klaus ^a   Völcker, Hans E ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

angiogenesis; cornea; genistein; macula

Indexed keywords

GENISTEIN; FIBROBLAST GROWTH FACTOR 2; GROWTH INHIBITOR; ISOFLAVONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CORNEA NEOVASCULARIZATION; NONHUMAN; RABBIT; SUBCONJUNCTIVAL DRUG ADMINISTRATION; ANIMAL; CAPILLARY; CONJUNCTIVA; CORNEA; DRUG EFFECT; INJECTION; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; VASCULARIZATION;

ANIMALS; CAPILLARIES; CONJUNCTIVA; CORNEA; FIBROBLAST GROWTH FACTOR 2; GENISTEIN; GROWTH INHIBITORS; INJECTIONS; ISOFLAVONES; NEOVASCULARIZATION, PATHOLOGIC; RABBITS;

EID: 0031064388     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003470050097     Document Type: Article

References (26)

1. Adlercreutz H (1990) Western diet and western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest Suppl 200:3-23
2. Akiyama T, Ishida J, Nakagawa S et al .(1987) Genistein, a specific inhibitor of tyrosinespecific protein kinases. J Biol Chem 262:5592-5595
3. BenEzra D (1978) Neovasculogenic ability of prostaglandins, growth factors and synthetic chemoatractants. Am J Ophthalmol 86:455-461
4. Chan CK, Kempin SJ, Noble SK, Palmer GA (1994) The treatment of choroidal neovascular membranes by alpha Interferon. An efficacy and toxicity study. Ophthalmology 101:289-300
5. Crum R, Szabo S, Folkman J (1985) A new class of steroids inhibits angiogenesis in the presence of heparin or heparin fragment. Science 230:1375-1378
6. D'Amato RJ, Loughnan MS, Flynn E, Folkman J (1994) Thalidom ide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 91:4082-4085
7. Ezekowitz A, Mulliken J, Folkman J (1985) Interferon alpha therapy of hemangiomas in newborns and infants. Br J Haematol [Suppl 1] 79:67-68
8. Folkman J, Szabo S, Stovroff M, McNeil P, Li W, Shing Y (1991) Duodenal ulcer. Discovery of a new mechanism and development of angiogenic therapy that accelerates healing. Ann Surg 214:414-427
9. Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T, Montesano R, Schweigerer L (1993) Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci USA 90:2690-2694
10. Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA (1995) Definition of two angiogenic pathways by distinct alpha, integrins. Science 270:1500-1502
11. Gruber BL, Marchese MJ, Kew R (1995) Angiogenic factors stimulate mast-cell migration. Blood 86:2488-2493
12. Hill TD, Dean NM, Mordan LJ et al. (1990) PDGF-induced activation of phospholipase C is not required for induction of DNA synthesis. Science 248:1660-1663
13. Koroma BM, Juan E de (1994) Phosphotyrosine inhibition and control of vascular endothelial proliferation by genistein. Biodiem Pharmacol 48:809-818
14. Kruse FE, Joussen AM, Rohrschneider K, Völcker HE (1995) Vergleich zwischen Methylzellulose und Hydron für die Induktion kornealer Neovaskularisationen. Ophthalmologe 92:586
15. Linassier C, Pierre M, LePecq JB, Pierre J (1990) Mechanism of action in NHI-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity. Biochem Pharmacol 39:187-193
16. Montesano R, Vassalli JD, Baird A, Guillemin R, Orci L (1986) Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci USA 83:7297-7301
17. Moses MA, Langer R (1991) Inhibitors of angiogenesis. Biotechnology 9:630-634
18. Muir C, Waterhouse J, Powell MT, Whelan S (1987) Cancer incidence in five continents, vol 5. International agency for research on cancer, Lyon
19. Okura A, Arakawa H, Oka H, Yoshinari T, Monden Y (1988) Effect of genistein on topoisomerase activity and on the growth of (Val 12) Ha-ras-transformed NIH 3T3 cells. Biochem Biophys Res Commun 157:183-189
20. Pelech SL, Olwin BB, Krebs EG (1986) Fibroblast growth factor treatment of swiss 3T3 cells activates a subunit S6 kinase that phosphorylates a synthetic peptide substrate. Proc Natl Acad Sci USA 83:5968-5972
21. Pepper MS, Montesano R (1990) Proteolytic balance and capillary morphogenesis. Cell Differ Dev 32:319-328
22. Setchell KDR, Adlercreutz H (1988) Mammalian ligans and phytoestrogens. In:Rowland IR (ed) Role of the gut flora in toxicity and cancer. Academic Press, New York London, pp 315-345
23. Sunderkötter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C (1994) Macrophages and angiogenesis. J Leukoc Biol 55:410-422
24. Troll W, Wiesner R, Shellabarger CJ, Holtzman S, Stone JP (1980) Soybean diet lowers breast tumor incidence in irradiated rats. Carcinogenesis 1:469-472
25. Ullrich A, Schlessinger J (1990) Signal transduction by receptors with tyrosine kinase activity. Cell 61:203-212
26. Yamashita Y, Kawada S-Z, Nakano H (1990) Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orbol. Biochem Pharmacol 39:737-744